{"abstract": "New drugs for hepatitis C and superhigh cholesterol succeeded in late-stage clinical trials, the developers of the products announced on Wednesday.", "web_url": "https://www.nytimes.com/2010/08/05/health/05drug.html", "snippet": "New drugs for hepatitis C and superhigh cholesterol succeeded in late-stage clinical trials, the developers of the products announced on Wednesday.", "lead_paragraph": "New drugs for hepatitis C and superhigh cholesterol succeeded in late-stage clinical trials, the developers of the products announced on Wednesday. But both drugs have side effects that could dampen sales, analysts said.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [], "headline": {"main": "Promising Results Reported for Cholesterol and Hepatitis C Drugs", "kicker": null, "content_kicker": null, "print_headline": "Promising Results Reported for Cholesterol and Hepatitis C Drugs", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Vertex Pharmaceuticals Incorporated", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Hepatitis", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Isis Pharmaceuticals Inc", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Genzyme Corp", "rank": 6, "major": "N"}], "pub_date": "2010-08-05T00:26:28+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d81bfdcf-038c-5ec3-8003-b71b9b33d02a", "word_count": 621, "uri": "nyt://article/d81bfdcf-038c-5ec3-8003-b71b9b33d02a"}